Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
154 hedge funds and large institutions have $778M invested in Silk Road Medical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 17 closing their positions.
563% more call options, than puts
Call options by funds: $25.3M | Put options by funds: $3.81M
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
124% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 17
49% more capital invested
Capital invested by funds: $521M → $778M (+$257M)
27% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 41
16% more funds holding
Funds holding: 133 → 154 (+21)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$18.9M |
| 2 |
TLP
Tri Locum Partners
New York
|
+$17.2M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$16.4M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$10.7M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$25.7M |
| 2 |
JFG
Jefferies Financial Group
New York
|
-$24.5M |
| 3 |
Goldman Sachs
New York
|
-$18.3M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$17.5M |
| 5 |
AC
Armistice Capital
New York
|
-$12.9M |
SILK Hedge Fund Activity: Q1 2024 in Review
154 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q1 2024, worth a combined $778M — up 49% from $521M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new SILK positions and 17 closed out — a net gain of 21 holders — while 52 added to existing stakes and 41 trimmed.
The largest buyer was Sofinnova Investments, opening a new position worth an estimated $18.9M. The largest seller was Morgan Stanley, cutting an estimated $25.7M.
- 154 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q1 2024, up from 133 in Q4 2023.
- Funds reported $778M of Silk Road Medical, Inc. Common Stock stock for Q1 2024, up 49% quarter-over-quarter.
- 38 funds opened new Silk Road Medical, Inc. Common Stock positions in Q1 2024 and 17 closed out, a net change of +21 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q1 2024 was Sofinnova Investments, an estimated $18.9M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $25.7M sold.
Based on aggregated 13F filings for Q1 2024.